Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy E Lovett-Racke

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
JCI Insight|January 7, 2021
A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balanceSaba I Aqel, Xiaozhi Yang, Emma E Kraus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2015
Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunityXiaoli Ding, Yaping Yan, Xing Li, et al.
Journal of Neuroimmunology|May 12, 2019
B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patientsAmy E Lovett-Racke, Matthew Gormley, Yue Liu, et al.
Journal of Neuroinflammation|December 4, 2016
Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7RαPatrick K Nuro-Gyina, Elizabeth L Rieser, Marissa C Granitto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2020
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosisEdward Fox, Amy E Lovett-Racke, Matthew Gormley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2012
miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosisKristen M Smith, Mireia Guerau-de-Arellano, Stefan Costinean, et al.
Annals of Neurology|May 4, 2010
Silencing Nogo-A promotes functional recovery in demyelinating diseaseYuhong Yang, Yue Liu, Ping Wei, et al.
The Journal of Clinical Investigation|March 6, 2002
Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosisNitin J Karandikar, Michael P Crawford, Xiao Yan, et al.
Molecular Pharmaceutics|January 18, 2014
Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated Peptide and dexamethasone in acetalated dextran microparticlesKevin J Peine, Mireia Guerau-de-Arellano, Priscilla Lee, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 21, 2022
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference ProceedingsCarolyn Goldschmidt, Steven L Galetta, Robert P Lisak, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
JCI Insight|January 7, 2021
A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balanceSaba I Aqel, Xiaozhi Yang, Emma E Kraus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2015
Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunityXiaoli Ding, Yaping Yan, Xing Li, et al.
Journal of Neuroimmunology|May 12, 2019
B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patientsAmy E Lovett-Racke, Matthew Gormley, Yue Liu, et al.
Journal of Neuroinflammation|December 4, 2016
Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7RαPatrick K Nuro-Gyina, Elizabeth L Rieser, Marissa C Granitto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2020
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosisEdward Fox, Amy E Lovett-Racke, Matthew Gormley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2012
miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosisKristen M Smith, Mireia Guerau-de-Arellano, Stefan Costinean, et al.
Annals of Neurology|May 4, 2010
Silencing Nogo-A promotes functional recovery in demyelinating diseaseYuhong Yang, Yue Liu, Ping Wei, et al.
The Journal of Clinical Investigation|March 6, 2002
Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosisNitin J Karandikar, Michael P Crawford, Xiao Yan, et al.
Molecular Pharmaceutics|January 18, 2014
Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated Peptide and dexamethasone in acetalated dextran microparticlesKevin J Peine, Mireia Guerau-de-Arellano, Priscilla Lee, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 21, 2022
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference ProceedingsCarolyn Goldschmidt, Steven L Galetta, Robert P Lisak, et al.
Pageof 7